Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maureen Achebe

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Transfusion|June 2, 2020
Clinical data for intravenous iron - debunking the hype around hypersensitivityMaureen Achebe, Thomas G DeLoughery
Blood|November 12, 2020
When non-Whiteness becomes a conditionLauren E Merz, Maureen Achebe
British Journal of Haematology|December 6, 2019
Sudden death in sickle cell disease: current experienceChijioke Nze, Brooke Fortin, Revital Freedman, et al.
Annals of Hematology|September 2, 2020
Clinical outcomes and healthcare utilization in patients with sickle cell disease: a nationwide cohort study of Medicaid beneficiariesRishi J Desai, Mufaddal Mahesri, Denise Globe, et al.
European Journal of Haematology|November 6, 2020
Clinical outcomes following bone marrow transplantation in patients with sickle cell disease: A cohort study of US Medicaid enrolleesMufaddal Mahesri, Sebastian Schneeweiss, Denise Globe, et al.
Telemedicine Journal and E-Health : the Official Journal of the American Telemedicine Association|January 6, 2023
Persistence of Unequal Access to Classical Hematology Telemedicine Visits by Race and Other Demographics During the COVID-19 PandemicMiriam A Osei, Lauren E Merz, Siyang Ren, et al.
Seminars in Hematology|November 24, 2024
Modernizing multiple myeloma clinical trial eligibility to improve equity and inclusivity by hematological parametersLauren Merz, Monique Hartley-Brown, Maureen Achebe, et al.
JAMA|February 5, 2020
Effects of Iron Isomaltoside vs Ferric Carboxymaltose on Hypophosphatemia in Iron-Deficiency Anemia: Two Randomized Clinical TrialsMyles Wolf, Janet Rubin, Maureen Achebe, et al.
The Lancet. Haematology|April 10, 2021
Voxelotor in adolescents and adults with sickle cell disease (HOPE): long-term follow-up results of an international, randomised, double-blind, placebo-controlled, phase 3 trialJo Howard, Kenneth I Ataga, Robert C Brown, et al.
Blood Advances|January 4, 2018
Randomized phase 2 trial of regadenoson for treatment of acute vaso-occlusive crises in sickle cell diseaseJoshua J Field, Elaine Majerus, Victor R Gordeuk, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Transfusion|June 2, 2020
Clinical data for intravenous iron - debunking the hype around hypersensitivityMaureen Achebe, Thomas G DeLoughery
Blood|November 12, 2020
When non-Whiteness becomes a conditionLauren E Merz, Maureen Achebe
British Journal of Haematology|December 6, 2019
Sudden death in sickle cell disease: current experienceChijioke Nze, Brooke Fortin, Revital Freedman, et al.
Annals of Hematology|September 2, 2020
Clinical outcomes and healthcare utilization in patients with sickle cell disease: a nationwide cohort study of Medicaid beneficiariesRishi J Desai, Mufaddal Mahesri, Denise Globe, et al.
European Journal of Haematology|November 6, 2020
Clinical outcomes following bone marrow transplantation in patients with sickle cell disease: A cohort study of US Medicaid enrolleesMufaddal Mahesri, Sebastian Schneeweiss, Denise Globe, et al.
Telemedicine Journal and E-Health : the Official Journal of the American Telemedicine Association|January 6, 2023
Persistence of Unequal Access to Classical Hematology Telemedicine Visits by Race and Other Demographics During the COVID-19 PandemicMiriam A Osei, Lauren E Merz, Siyang Ren, et al.
Seminars in Hematology|November 24, 2024
Modernizing multiple myeloma clinical trial eligibility to improve equity and inclusivity by hematological parametersLauren Merz, Monique Hartley-Brown, Maureen Achebe, et al.
JAMA|February 5, 2020
Effects of Iron Isomaltoside vs Ferric Carboxymaltose on Hypophosphatemia in Iron-Deficiency Anemia: Two Randomized Clinical TrialsMyles Wolf, Janet Rubin, Maureen Achebe, et al.
The Lancet. Haematology|April 10, 2021
Voxelotor in adolescents and adults with sickle cell disease (HOPE): long-term follow-up results of an international, randomised, double-blind, placebo-controlled, phase 3 trialJo Howard, Kenneth I Ataga, Robert C Brown, et al.
Blood Advances|January 4, 2018
Randomized phase 2 trial of regadenoson for treatment of acute vaso-occlusive crises in sickle cell diseaseJoshua J Field, Elaine Majerus, Victor R Gordeuk, et al.
Pageof 2